14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 4.377 1 day ( 0 % )
Last Price $0.400 10.68 %
High/ Low $0.356 - $0.400 18.17%
Chg 7 Days 8.58 % $0.368 $0.400
Chg 30 Days 24.92 % $0.320 $0.400
Chg 12 mos 29.03 % $0.310 $0.400
Trend - 3 mos -3.92 % Width: 39.84 %
Trend - 12 mos -50.94 % Width: 208.49 %
Pred. range - 3 mos $0.287 - $0.401 -28.37 % - 0.168 %
Pred. range - 12 mos N/A - $1.30 -100.00 % - 225.89 %
Short MA avg 3 mos Buy Apr 23, 2024 - 2 days
Long MA avg 3 mos Sell Apr 15, 2024 - 8 days
Short/Long MA avg 3 mos Buy Apr 09, 2024 - 12 days
Short MA avg 12 mos Buy Apr 04, 2024 - 15 days
Long MA avg 12 mos Buy Apr 23, 2024 - 2 days
Short/Long MA avg 12 mos Sell Jul 28, 2023 - 187 days
Pivot Short Sell Apr 16, 2024 - 7 days
Bollinger Buy Mar 15, 2024 - 28 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT